Peptide-Based Drug Design: Here and Now
- 1 January 2008
- book chapter
- research article
- Published by Springer Science and Business Media LLC
- Vol. 494, 1-8
- https://doi.org/10.1007/978-1-59745-419-3_1
Abstract
After many years of stagnation, peptide therapeutics once again became the focus of innovative drug development efforts backed up by venture funds and biotechnology companies. Designer peptide drugs overcome the unattractive pharmacological properties of native peptides and protein fragments and frequently feature nonnatural amino acid or backbone replacements, cyclic or multimeric structures, or peptidic or nonpeptidic delivery modules. With their high specificity and low toxicity profile, biologicals offer viable alternatives to small molecule therapeutics. The development of peptide drugs requires specific considerations of this family of biopolymers. Historically, peptide vaccines to viral infections and antibacterial peptides led the way in clinical development, but recently many other diseases have been targeted, including the big sellers AIDS, cancer, and Alzheimer’s disease. This book gives practical advice to the most important steps in peptide-based drug development such as isolation, purification, characterization, interaction with targets, structural analysis, stability studies, assessment of biodistribution and pharmacological parameters, sequence modifications, and high throughput screening. This brief overview provides historical background for each of the listed techniques and diseases.Keywords
This publication has 26 references indexed in Scilit:
- SOM230, A New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary AdenomasClinical Cancer Research, 2007
- Crystal Structures of a High-affinity Macrocyclic Peptide Mimetic in Complex with the Grb2 SH2 DomainJournal of Molecular Biology, 2005
- Evaluation of Drug Penetration into the Brain: A Double Study by in Vivo Imaging with Positron Emission Tomography and Using an in Vitro Model of the Human Blood-Brain BarrierThe Journal of pharmacology and experimental therapeutics, 2005
- Current strategies for the development of peptide‐based anti‐cancer therapeuticsJournal of Peptide Science, 2005
- Keynote review: Progress in targeting HIV-1 entryDrug Discovery Today, 2005
- Antibacterial peptides and proteins with multiple cellular targetsJournal of Peptide Science, 2005
- Peptide leads new class of chronic pain drugsNature Biotechnology, 2005
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005
- Role of SA–Lea and E-selectin in metastasis assessed with peptide antagonistPeptides, 2002
- Antimicrobial peptides of multicellular organismsNature, 2002